Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Prostatic Neoplasms 6Neoplasms 5Breast Neoplasms 3Testicular Neoplasms 2Polycystic Ovary Syndrome 2Sleep Apnea, Obstructive 1Sleep Apnea Syndromes 1Sexuality 1Sexual Dysfunction, Physiological 1Obesity 1Neoplasm Metastasis 1Muscle Weakness 1Multiple Endocrine Neoplasia Type 1 1Motor Activity 1Metabolic Syndrome 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Infertility 1Hypogonadism 1Hot Flashes 1Fatigue 1Dyspareunia 1Arthralgia 1

Interventions

Psychiatric Rehabilitation 4Counseling 3Sildenafil Citrate 2methyl N-acetylsibirosaminide 1Testosterone Propionate 1Testosterone 1Radiotherapy 1Prostatectomy 1Pilocarpine 1Phentolamine 1Papaverine 1Mental Status and Dementia Tests 1Educational Status 1Diet Therapy 1Arginine 1ArginMax 1Alprostadil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Sexuality × Testosterone × Clear all
NCT04492553 2022-11-29

Vitality

Herlev Hospital

Phase 2 Completed
7 enrolled
Lymphoid

Hypogonadism, Lymphoma, Neoplasms, Lymphoma, Large B-Cell, Diffuse, Sexuality

Data powered by HemOnc (CC BY 4.0) Colophon âš¡